In general, financial media has been undecided on the outlook of PhotoMedex, Inc.
Table Summary: Sentiment Analysis of Recent Headlines
|% Positive Headlines||29.17||40|
|% Negative Headlines||6.25||13|
|% Neutral Headlines||64.58||47|
Sample of Recent Headlines Processed by Our Sentiment Algorithms, Classified as Positive (Access Stock Sentiment Analysis Here)
- PhotoMedex Turns To Profit In Q4 - Quick Facts
- InPlay: PhotoMedex beats by $0.06; beats on revs
- UPDATE: Canaccord Raises PT to $19.50 on PhotoMedex on Solid Q412 Earnings Beat
- PhotoMedex Inc. Enters Oversold Territory - Tale of the Tape
- PhotoMedex Inc. Enters Oversold Territory
- Skin Care Company PhotoMedex Expected To Clean Up Nicely
- PhotoMedex (NASDAQ:PHMD): Zacks Rank Buy
- UPDATE 1-PhotoMedex sees Q4 revenue topping estimates
- PhotoMedex Supports Psoriasis And Vitiligo Patients Through New "Live Clear. ...
Sample of Recent Headlines Processed by Our Sentiment Algorithms, Classified as Negative (Access Stock Sentiment Analysis Here)
- PhotoMedex Announces Settlement Of All Litigation With TRIA
- PhotoMedex Stock Falls On Unusually High Volume (PHMD)
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.